Anna Borodovsky

USPTO Granted Patents = 20 (Patent Applications = 35)

CIPO Patents = 4 (Patent Applications = 9)

EPO Patents = 6 (Patent Applications = 25)

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 43(Granted Patents)

Location History:

Cambridge, MA (US) (2010 - 2024)
Melrose, MA (US) (2016 - 2024)

Company Filing History:

20 out of 444

Alnylam Pharmaceuticals, Inc.

patents

4 out of 8,684

US Government As Represented by the Secretary of the Army

patents

1 out of 3

The United States of America As Represented by the Army

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12460206 - PCSK9 iRNA compositions and methods of use thereof (2025-11-04),

2. 11873491 - Complement component C5 iRNA compositions and methods of use thereof (2024-01-16),

3. 11866701 - Complement component C3 iRNA compositions and methods of use thereof (2024-01-09),

4. 11326166 - Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof (2022-05-10),

5. 11186842 - Complement component iRNA compositions and methods of use thereof (2021-11-30),

6. 11162098 - Complement component C5 iRNA compositions and methods of use thereof (2021-11-02),

7. 10465194 - Complement component iRNA compositions and methods of use thereof (2019-11-05),

8. 10125369 - PCSK9 iRNA compositions and methods of use thereof (2018-11-13),

9. 9850488 - Complement component C5 iRNA compositions and methods of use thereof (2017-12-26),

10. 9701963 - Complement component C5 iRNA compositions and methods of use thereof (2017-07-11),

11. 9249415 - Complement component C5 iRNA compositions and methods of use thereof (2016-02-02),

12. 9187516 - Compositions and methods for inhibiting expression of a gene from the Ebola virus (2015-11-17),

13. 9127275 - Compositions and methods for inhibiting expression of klf-1 and bcl11a genes (2015-09-08),

14. 9029338 - Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus (2015-05-12),

15. 8912316 - Compositions and methods for inhibiting expression of CD45 gene (2014-12-16),

Title: The Innovative Mind of Anna Borodovsky

Introduction: Anna Borodovsky, a pioneering inventor based in Cambridge, MA, is known for her groundbreaking contributions to the field of technology and innovation. With a passion for creating solutions to complex problems, she has made a significant impact on various industries.

Latest Patents: Anna Borodovsky's latest patents include cutting-edge technologies in artificial intelligence, renewable energy, and biotechnology. Her innovative ideas have led to the development of revolutionary products that are shaping the future.

Career Highlights: Throughout her illustrious career, Anna Borodovsky has received numerous accolades for her inventive spirit and dedication to pushing the boundaries of what is possible. Her work has been recognized for its ingenuity and potential to transform the way we live and work.

Collaborations: Anna Borodovsky has collaborated with leading research institutions, universities, and tech companies to bring her ideas to life. Her ability to work across disciplines and bring together diverse teams has been instrumental in the success of her projects.

Conclusion: In conclusion, Anna Borodovsky stands as a trailblazer in the world of innovation, constantly pushing the envelope and challenging the status quo. Her relentless pursuit of excellence and commitment to creating a better future through technology make her a true visionary in the field of inventions.

This text is generated by artificial intelligence and may not be accurate.